CAT vs STRO
Caterpillar Inc (CAT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CAT and STRO stock pages for the full models.
Not investment advice.